JOSÉ JAVIER
FERNÁNDEZ RUIZ
Catedrático de universidad
Hospital Ramón y Cajal
Madrid, EspañaHospital Ramón y Cajal -ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2016
-
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease
Journal of Neurology, Vol. 263, Núm. 7, pp. 1390-1400
2013
-
Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy
Journal of Alzheimer's Disease, Vol. 35, Núm. 3, pp. 525-539
2011
-
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease
Brain, Vol. 134, Núm. 1, pp. 119-136
2009
-
Cannabinoid CB1 receptors are early DownRegulated followed by a further UpRegulation in the basal Ganglia of mice with deletion of specific park genes
Journal of Neural Transmission, Supplementa, pp. 269-275
2005
-
Cannabinoid CB1 receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice
Brain Research, Vol. 1046, Núm. 1-2, pp. 195-206